Impairment in exploratory behavior is associated with arc gene overexpression in the dorsolateral striatum of rats with nigral injection of l-buthionine sulfoximine

Neurosci Lett. 2018 Nov 20:687:26-30. doi: 10.1016/j.neulet.2018.09.026. Epub 2018 Sep 14.

Abstract

The aims of the present work were to evaluate the exploratory activity in Sprague-Dawley rats, as well as to analyze the nigral and striatal mRNA expression of the plasticity-related genes bdnf and arc after L-buthionine sulfoximine (BSO) injection into substantia nigra compacta. Lesioned rats traveled less distance in open field but did not show a decline in the novel object recognition test. On the other hand, RT-PCR analysis showed overexpression of striatal arc 24 h post-lesion; no significant changes in bdnf expression were observed in nigral or striatal tissue. These results suggest that intranigral BSO injection causes impairment in exploratory behavior in these rats, by affecting locomotion, which is associated with changes in striatal synaptic plasticity.

Keywords: Basal ganglia; Glutathione; Novel object recognition; Plasticity; l-buthionine sulfoximine.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Buthionine Sulfoximine / administration & dosage
  • Buthionine Sulfoximine / toxicity*
  • Corpus Striatum / drug effects
  • Corpus Striatum / metabolism*
  • Cytoskeletal Proteins / biosynthesis*
  • Cytoskeletal Proteins / genetics
  • Exploratory Behavior / drug effects
  • Exploratory Behavior / physiology*
  • Gene Expression
  • Injections, Intraventricular
  • Male
  • Nerve Tissue Proteins / biosynthesis*
  • Nerve Tissue Proteins / genetics
  • Random Allocation
  • Rats
  • Rats, Sprague-Dawley
  • Substantia Nigra / drug effects
  • Substantia Nigra / metabolism*

Substances

  • Cytoskeletal Proteins
  • Nerve Tissue Proteins
  • activity regulated cytoskeletal-associated protein
  • Buthionine Sulfoximine